Published on: December 09, 2019 at 10:30PM
Conditions: Diabetes Mellitus, Type 2; Renal Insufficiency, Chronic
Intervention: Other: Inteprofessional medication adherence support program (IMAP)
Sponsors: Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland; pharmaSuisse; santésuisse; Curafutura
Recruiting
https://ift.tt/2DZrGzp
Monday 9 December 2019
New diabetes clinical trial: PANDIA IRIS: Patients With Diabetes and Kidney Failure, an Interdisciplinary Medication Adherence Support Program
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.